Dr. John Mikhail is a trained pulmonary & critical care physician. His role at the ACMA is to provide medical advisory services. He also assists the ACMA in bridging the gap between the needs of the medical community and the overall mission of the ACMA. He also provides important oversight of the BCMAS program ensuring that it is up to date and continuously improved to meet the needs of medical affairs professionals who partner with academic centers of excellence. He earned his BA in Psychology from Rutgers University and his MD from Ross University School of Medicine.
Sam Rasty is an associate professor of Clinical & Administrative Sciences at the California Northstate University College of Pharmacy (CNUCOP). He received his Doctor of Pharmacy degree from the Ferris State University. After graduation, Dr. Rasty completed a Cardiovascular Pharmacotherapy Fellowship at Henry Ford Hospital in Detroit, MI. Dr. Rasty was the clinical coordinator in cardiac and medical intensive care unit at Advocate Christ Medical Center and since 2004 has held various academic, and pharmaceutical industry positions in Medical and Regulatory affairs prior to joining CNUCOP. Most recently Dr. Rasty completed a Master’s degree in public health with a focus in epidemiology. Dr. Rasty’s research primarily focuses on patient health outcomes in cardiovascular pharmacotherapy.
Dr. Kanmaz has served on the faculty at St. John’s University, College of Pharmacy and Health Sciences since 1996 with an interim three-year appointment as an HIV Clinical Science Manager at Abbott Laboratories. During her time at Abbott, she served as the HIV clinical expert for the 5 boroughs of New York, attended national and international HIV/AIDS conferences, developed and presented post-conference educational slide decks, collaborated on phase IV investigator-initiated studies, developed key opinion leaders, participated in regional advisory board meetings, and supported the sales and marketing teams.
She is currently the Assistant Dean for Experiential Pharmacy Education and Associate Clinical Professor in the Department of Clinical Health Professions. She has received several grants directed toward the care of patients with HIV/AIDS and disadvantaged persons in high poverty situations. She is certified as an American Academy of HIV Medicine HIV Expert as well as a certified Smoking Cessation Counselor. Dr. Kanmaz is also an active member of several committees within the American Association of Colleges of Pharmacy10, Experiential Education Special Interest Group.
Dr. Mehul Patel has more than 11 years of experience within the pharmaceutical and medical communications industry. He is currently employed as a Director of Medical Affairs at Allergan, providing medical leadership for the cardiovascular, metabolic and psychiatry portfolio. Responsibilities include developing aligned global medical strategic plans and providing medical input into tactical activities within these therapeutic areas. He as has authored multiple publications and has conducted numerous live CME and non CME lectures. In addition to his current role, Mehul gained his medical affairs/communications experience at PDL BioPharma and at Embryon Inc.. In addition, he spent five years working as a clinical program lead at Biogen Idec where his responsibilities included constructing strategic clinical development plans for drug candidates in the cardiovascular, CNS and immunology therapeutic areas.
Dr. Patel received his doctorate in pharmacy at the Ernest Mario School of Pharmacy (Rutgers University).
Dr. Mehal is currently Associate Professor of Medicine (Digestive Diseases), Director of Yale Weight Loss Program and liver transplantation center. He is Board Certified in Gastroenterology and Internal Medicine. He has well over 75 publications including book chapters focused in hepatology. He is well regarded in the area of hepatology and has played an important role leading the discussion on the therapeutic landscape of weight management. This area has changed with the introduction of new and well tested weight loss medications, and the intra-gastric balloons. The weight loss program Dr. Mehal oversees brings all non-surgical weight loss components into a single place and include lifestyle/dietary interventions, psychological (Mindfulness training), medications, meal replacement (Optifast) and endoscopic approaches (gastric balloon). This Program also has links to specialty clinics such a diabetes, sleep apnea, hepatology, and has a dedicated EPIC department with outcomes tracker capacity so that outcomes can be quantified and associated with different management decisions. Dr. Mehal received his MD, DPhil, and BA from the University of Oxford..
In his current role, Dr. Mehal plays a critical role in helping the field of hepatology evolve in the areas of HIV, weight loss and liver transplant.
Marianne Kenny, PharmD is a senior level medical affairs executive in the pharmaceutical industry with over 27 years of experience. She has had extensive experience leading global processes and technology initiatives within the medical information, promotion review, publication planning, knowledge management, grants and investigator-initiated trials, integrating and streamlining these functions each time a new company was acquired. Marianne is an accomplished leader with a track record of building corporate value and leveraging strong industry acumen. She has expertise in assembling high-performance teams and providing the leadership and guidance that meets synergy targets and continuing functionality of medical departments under corporate integrity agreements. She has worked with several organizations including Grunenthal Pharmaceuticals, Watson, Actavis, and Allergan Pharmaceuticals as Vice President of Global Medical Communications and Professional Affairs. Currently she is with Bayer in Medical Affairs. She holds a Doctor or Pharmacy degree from the University of the Sciences.
There is a relatively small segment of leaders in the business world; individuals with leadership and the ability to leverage their knowledge and education to achieve aggressive goals while building trust and relationships and rapport and motivating forward momentum to achieve goals.
Jim Berlanti, MD is one of those professionals, who throughout his career possess a proven record of success driving results through collaboration, partnerships, and relationships as both an Internist with his peers and a Medical Strategist in the healthcare industry. With enthusiasm Jim radiates a sincere passion for delivering value and benefits to agencies, clients and business units.
As the Chief Medical Officer for one of the world’s largest healthcare agencies, Jim created and led a scientific team and a global network of expert advisors, which consistently identified untapped opportunities through market analysis and led to the success of numerous category leaders including Crestor, Enbrel, Seroquel, Prilosec/Nexium and Ambien. Jim’s role was expanded to uncover insights across brands and agencies, worldwide, for the worlds largest healthcare communications network Publicis Healthcare. He was part of the global new business team G7.
He was part of the Saatchi/Pharmacia team that was instrumental in working with FDA and KOLs redefining a category, OAB, for Detrol, when Detrol did not meet it’s primary endpoint.. OAB was created specifically as a consumer driven term. OAB developed into a multi-billion dollar category.
In 2008, Saatchi and Saatchi were named “Agency of the Year”. As part of the Saatchi management team he also was part of the global new business team. Jim devoted 60-70 % of his time to new business pitches across all promotional venues. In 2009 Saatchi won 29 new business pitches.
Jim’s expertise and experience across virtually every therapeutic category is current as are the insights he has, he has the ability to see the commercial opportunity within evolving market dynamics, and he has an unmatched network of experts who will speak to him with more authenticity peer to peer because of their respect for him.
From an Internist’s perspective, Jim brings advanced medical knowledge and insight to the MD audiences, with the documented ability to communicate current and future medical trends, within the physician and pharmaceutical communities. He has expert insights into all the specialties, both at the KOL level, as well as the PCP and the community specialists, by market. He has the ability to speak about the disease states across categories. Jim has built a very large network of key opinion leaders and academic community physicians across many specialties and global marketplaces. He also has a working knowledge of FDA and other regulatory agencies.
Jim joined Havas World Wide in April of 2014 as SVP Medical Director. He worked on a new PCSK9 monoclonal antibody that is coming to market for hyperlipidemia. His other responsibilities included working as an internal consultant across the global network. He went on to work at Noven Pharmaceuticals, Harrison & Star and Ogilvy where he was part of the Agency/Client Xeljanz team, due to his category experience, having launched Enbrel and basically having touched every new entry into that space.
Jim holds a Bachelor of Arts in science from the College of the Holy Cross and a Doctor of Medicine from Mt. Sinai Icahn School of Medicine in New York City. After completing his residency in Internal Medicine at Mt. Sinai Icahn School of Medicine at Elmhurst, Jim served as a staff and faculty member at NYU/Bellevue Hospital Medical Center for two years. He then moved into Advertising.
With many key accomplishments, Jim has more than 27 year of success Agency side supporting customer centric agencies bridging the gap between agencies, physicians and pharmaceutical companies focusing on current and future product trends supported by successful communications assisting agencies in reaching and exceeding their revenue goals.
Julio Casoy has been Senior Vice President of Medical Affairs for Sepracor, Inc. since August 19, 2008. He joined Sepracor from Shire Pharmaceuticals where he served as Senior Vice President of Global Medical Affairs in 2005. Dr. Casoy served as Vice President of Global Medical Affairs, Compliance and Intercontinental Medical Director at Wyeth.
Dr. Casoy received his medical degree from Universidade Federale de Sao Paulo.
Dr. Korner brings extensive medical affairs and clinical development experience to ACMA Advisory Board, having contributed to the FDA approvals and launch of numerous drugs and devices across multiple therapeutic areas.
Dr. Korner has 20 years of pharmaceutical/biotech industry experience, having served in various leadership positions of increased responsibility with several global companies. He currently serves as Vice President, Global Medical Strategy & Clinical Development for Sarepta Therapeutics, a biopharmaceutical company focused on the discovery and development of precision genetic medicines to treat rare neuromuscular diseases. Prior to Sarepta, he served as Chief Medical Officer for Ardelyx Inc., developing first in class medicines to better the lives of underserved patients with GI & renal diseases. Paul also served as President, Ferring International Pharmascience Center U.S. Inc. (FIPCUS) & Senior Vice President, U.S. Development for Ferring Pharmaceuticals where he built and led Ferring’s U.S. Clinical Development subsidiary responsible for gastroenterology, reproductive health, orthopedics and urology therapeutic areas and was a member of senior global R & D management. Dr. Korner joined Ferring in 2008 as Vice President, Medical Affairs, responsible for pharmacovigilance, medical information and medical staff supporting Ferring’s marketed products.
Prior to joining Ferring, Dr. Korner was Vice President of Medical Affairs, Female Health at Bayer HealthCare Pharmaceuticals, where his group supported the U.S. business unit and Phase 2 to Phase 4 development projects. He also served as Senior Director of Clinical Research and Development, Women’s Health and Musculoskeletal Bone Repair for Wyeth Research and as Director, Medical Affairs – GI and Women’s Health for Solvay Pharmaceuticals.
Dr. Korner is a board-certified obstetrician and gynecologist. He received his MD from Loyola University, Stritch School of Medicine in Illinois. He also holds an MBA from the Michael J. Coles College of Business at Kennesaw State University in Georgia.
Shalini Vallabhan is a social impact leader with experience working with private, public, and non-profit sectors in the U.S. and across the Asia region. She is currently managing director of government relations for the American Cancer Society Cancer Action Network and is overseeing advocacy work in Maine, Massachusetts, New Hampshire, and Rhode Island, and strategic partnership development in the greater Boston and New York City areas.
Shalini is dedicated to improving health around the world. After completing her PhD with a focus on health policy, she served as a legislative aide in the US Congress. Then Shalini directed the policy research team for the American Cancer Society and went on to become the ACS strategic director of Asia programs where she launched in-country training programs in India, China, and Southeast Asia for community-based organizations and governments. In 2009, Shalini moved to India to join the International Union Against Tuberculosis and Lung Disease to help build public health capacity within governments and non-governmental organizations in Bangladesh, India, and Indonesia. She is currently serving as the chair of Pallium India USA, a US based non-profit dedicated to improving access to palliative care across India.
Shalini holds a PhD in political science from Texas A&M University and is an INSEAD alumna. She was a Fellow with the University of Wisconsin-Madison working to improve access to affordable and effective pain medications across India.
Toll Free : 1-855-255-7137
55 Oak Street
Suite 201, Unit C
Norwood, NJ 07648 USA
Rio de Janieiro St 212, Suite 151
Sao Paulo, SP 01240-010 Brasil
202, Jai Omkar, Plot No. 36, Sector 20,
Airoli, Navi Mumbai, India - 400 708